Cargando…

Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation

VP1, a pivotal capsid protein encoded by the foot-and-mouth disease virus (FMDV), plays an important role in receptor-mediated attachment and humoral immune responses. Previous studies show that amino acid changes in the VP1 protein of cell culture-adapted strains of FMDV alter the properties of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekanayaka, Pathum, Lee, Seo-Yong, Herath, Thilina U. B., Kim, Jae-Hoon, Kim, Tae-Hwan, Lee, Hyuncheol, Chathuranga, Kiramage, Chathuranga, W. A. Gayan, Park, Jong-Hyeon, Lee, Jong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723281/ https://www.ncbi.nlm.nih.gov/pubmed/33232374 http://dx.doi.org/10.1371/journal.ppat.1009057

Ejemplares similares

Inhibition of MAVS Aggregation-Mediated Type-I Interferon Signaling by Foot-and-Mouth Disease Virus VP3
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

Foot-and-Mouth Disease Virus 3C(pro) Cleaves BP180 to Induce Blister Formation
por: Ekanayaka, Pathum, et al.
Publicado: (2022)

Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus
por: Ekanayaka, Pathum, et al.
Publicado: (2021)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2
por: Chathuranga, Kiramage, et al.
Publicado: (2020)

Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes
por: Park, Jong Hyeon, et al.
Publicado: (2006)

Anti-Respiratory Syncytial Virus Activity of Plantago asiatica and Clerodendrum trichotomum Extracts In Vitro and In Vivo
por: Chathuranga, Kiramage, et al.
Publicado: (2019)

Fas-associated factor 1 mediates NADPH oxidase-induced reactive oxygen species production and proinflammatory responses in macrophages against Listeria infection
por: Kim, Tae-Hwan, et al.
Publicado: (2019)

African Swine Fever Virus (ASFV): Immunity and Vaccine Development
por: Chathuranga, Kiramage, et al.
Publicado: (2023)

Production of foot-and-mouth disease virus SAT2 VP1 protein
por: Mamabolo, Mpho Victoria, et al.
Publicado: (2020)

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5
por: Weerawardhana, Asela, et al.
Publicado: (2022)

Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A
por: Chathuranga, W. A. Gayan, et al.
Publicado: (2022)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1
por: Alam, SM Sabbir, et al.
Publicado: (2013)

Evolutionary Analysis of Structural Protein Gene VP1 of Foot-and-Mouth Disease Virus Serotype Asia 1
por: Zhang, Qingxun, et al.
Publicado: (2015)

Foot-and-mouth disease virus VP1 promotes viral replication by regulating the expression of chemokines and GBP1
por: Yang, Li, et al.
Publicado: (2022)

Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response
por: Kim, Sae-Hae, et al.
Publicado: (2013)

Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O
por: Bai, Xing-Wen, et al.
Publicado: (2019)

African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2′3′-cGAMP
por: Ranathunga, Lakmal, et al.
Publicado: (2023)

Infectious pancreatic necrosis virus proteins VP2, VP3, VP4 and VP5 antagonize IFNa1 promoter activation while VP1 induces IFNa1
por: Lauksund, Silje, et al.
Publicado: (2015)

Identification of H-2d Restricted T Cell Epitope of Foot-and-mouth Disease Virus Structural Protein VP1
por: Liu, Xin-Sheng, et al.
Publicado: (2011)

The Kinase STK3 Interacts with the Viral Structural Protein VP1 and Inhibits Foot-and-Mouth Disease Virus Replication
por: Liu, Huisheng, et al.
Publicado: (2017)

Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region
por: Lv, Ke, et al.
Publicado: (2009)

Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease Virus
por: Gong, Saisai, et al.
Publicado: (2020)

The VP3 Protein of Bluetongue Virus Associates with the MAVS Complex and Interferes with the RIG-I-Signaling Pathway
por: Pourcelot, Marie, et al.
Publicado: (2021)

Intracellular sensing of viral genomes and viral evasion
por: Lee, Hyun-Cheol, et al.
Publicado: (2019)

Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells
por: Kristensen, Thea, et al.
Publicado: (2017)

A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity
por: Dong, Hu, et al.
Publicado: (2021)

Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing
por: Chathuranga, Kiramage, et al.
Publicado: (2021)

Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1
por: Wang, Miao, et al.
Publicado: (2015)

Poly (rC) binding protein 2 interacts with VP0 and increases the replication of the foot-and-mouth disease virus
por: Li, Dan, et al.
Publicado: (2019)

The upregulation of peripheral blood polyamine metabolites spermidine and spermine in children with hand, foot, mouth disease is related to enterovirus 71 capsid protein VP1, but not VP4
por: Li, Cong, et al.
Publicado: (2023)

Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine
por: Ahn, Young-Hoon, et al.
Publicado: (2021)

Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus
por: Xue, Mei, et al.
Publicado: (2012)

Inhibitory Effect of Sargassum fusiforme and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo
por: Chathuranga, Kiramage, et al.
Publicado: (2021)

Correction: Codon Optimization, Expression in Escherichia coli, and Immunogenicity of Recombinant Chinese Sacbrood Virus (CSBV) Structural Proteins VP1, VP2, and VP3
por: Fei, Dongliang, et al.
Publicado: (2015)

Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C
por: Kuroda, Makoto, et al.
Publicado: (2015)

The novel immunobiotic Clostridium butyricum S-45-5 displays broad-spectrum antiviral activity in vitro and in vivo by inducing immune modulation
por: Chathuranga, Kiramage, et al.
Publicado: (2023)

Foot-and-Mouth Disease Virus Capsid Protein VP1 Interacts with Host Ribosomal Protein SA To Maintain Activation of the MAPK Signal Pathway and Promote Virus Replication
por: Zhu, Zixiang, et al.
Publicado: (2020)

Antigenicity and Immunogenicity Analysis of the E. coli Expressed FMDV Structural Proteins; VP1, VP0, VP3 of the South African Territories Type 2 Virus
por: Li, Guoxiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6kfvgf2p58v4i9hlv6cbvk97vm